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Marcia Angell, Editor-in-Chief of the New England Journal of Medicine, once
said, “…our health care system creates ethical dilemmas that no health care system
should create” (Angell). One of these ethical dilemmas is the lack of insurance coverage
for hearing assistance devices and surgeries, which add to the quality of a person’s life.
Hearing is one of the five major senses, but millions of Americans are hearing impaired
throughout the U.S. The largest populations in the United States affected by hearing loss
are the elderly and the aging generation of baby boomers. In fact, 25% of adults over age
65 experience disabling hearing loss (Quick Statistics). Recent studies demonstrate that,
“Severity of hearing loss is associated with reduced quality of life in older adults”
(Dalton). Another study, the Blue Mountain Hearing Study, also identified the “disease
burden of age-related hearing impairment on health-related quality of life in a populationbased cohort of older persons” (Chia). The lack of coverage for services to aid in the
restoration or partial-restoration of hearing should be considered a gross inequity in the
world’s most medically advanced country.
The elderly may often take center stage on this issue but the effects of hearing
loss are widespread and can be found in all age groups and socio-economic classes.
According to the U.S. Department of Health and Human Services, “About 2 to 3 out of
every 1,000 children in the United States are born with a detectable level of hearing loss
in one or both ears” (Quick Statistics). In addition, 90% of children born with hearing
loss are born to hearing parents who do not understand their child’s condition fully
because they have not experienced it themselves. One in eight Americans twelve years of
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age or older suffer from hearing loss in one or both ears. This statistic constitutes 13% of
the population of the U.S. or 30 million Americans. (Quick Statistics). In addition a
recent study by Dr. Judith E. Cho Lieu, noted among children and youth grade failure as
well as speech impairment and delays are negative results of childhood hearing loss,
which negatively affect social skill development, often resulting in behavioral problems
(Cho Lieu).
There are three types of hearing loss, which are responsible for these statistics.

Conductive hearing loss is due to problems with the ear canal, eardrum, or the middle ear,
which is home to many small bones. Sensorineural hearing loss is due to inner ear
problems and nerve problems. Mixed hearing loss is a combination of the two types
previously mentioned (Types, Causes, Treatments). There are also various levels to each
of these types of loss: mild, moderate, severe, or profound. Mild hearing loss means that
the individual will have some trouble keeping up with conversations, especially in noisy
environments. Moderate hearing loss means an individual will have trouble keeping up
with conversations without the use of a hearing aid. Severe hearing loss sufferers greatly
benefit from hearing aids but often rely heavily on lip reading even when they do use
them. Many people with severe loss sign as well. Profound hearing loss means that the
person relies almost completely on lip reading and sign language but occasionally they
can hear very loud sounds (What are the different degrees of hearing loss?).
There are various treatment options for each type of hearing loss. The most
common treatment is wearing hearing aids, which are used in cases where medicine and
surgery are not suitable for the patient or are too expensive. Many factors such as
listening needs, lifestyle, and individual hearing loss impact which kind of hearing aids
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will best suit a patient. Hundreds of different makes and models of external hearing aids
can be found in the U.S. market today. Patients can expect to pay anywhere from $1,000
to $8,000 for a pair of custom hearing aids, most of which are not covered by insurance.
A single hearing aid can cost up to $600 (Hearing Aid Buying Guide). Hearing aid

purchases reached a peak in 2008 when the binaural purchase rate increased 78.8% for all
users. New hearing aid owners, however, decreased by 39.9% as the price of hearing aids
rose (Kochkin). Hearing aids are the third most widely used assistive medical device in
this country after canes and eyeglasses. Nevertheless, most Americans with hearing loss
do not use hearing aids; “Of the estimated 23.5 million Americans with hearing loss, only
about 3.78 to 5 million own hearing aids” (Adams 1).
Cochlear implants are another device that can improve the condition of people
with severe and irreparable hearing loss. These small devices surgically implanted in the
ear can help a person to hear and understand more speech than is possible with even the
best external hearing aid (Hearing Loss Treatment). Cochlear implants consist of an
external portion, which sits behind the recipient’s ear and an internal portion, which is
surgically implanted under the recipient’s skin. This one small device consists of a
microphone to amplify environmental sounds, a speech processor, which arranges sounds
picked up by the microphone, a transmitter, which converts the sounds into electrical
impulses, and an electrode array, which collects the impulses and sends them to the
auditory nerves. As of December 2012, about 58,000 adults and 38,000 children had
received this type of implant in the United States. Some insurance companies may cover
the expense of this surgery or a portion, but not always (Cochlear Implants). The average
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cost for the entire procedure including post-operative rehabilitation often exceeds
$40,000 (Cochlear Implant Frequently Asked Questions).

An examination of current standard health insurance policies on hearing problems
illuminates the commoditization of this portion of healthcare. The treatment of hearing
aids as market commodities means the devices are only available to those who can pay
for them out of their own pockets. The best example from the insurance sector to use here
is the case of Medicaid. Medicaid provides assistance for low-income individuals who
qualify. The new terms of qualification set out by the Affordable Care Act expand
Medicaid coverage to every American under age 65 with an income below 138% of the
federal poverty line unless they receive insurance through another source, such as an
employer (Ezekiel pp. 207). Both the state and federal governments jointly fund the
program. Each state has flexibility under the broad guidelines set out for Medicaid.
Remarkably, hearing health services are optional under the Federal guidelines for
minimum coverage set out for Medicaid. As a result, many states do not cover adult
hearing health services, even though a federally mandated program covers children until
the age of 18 in all fifty states through a program known as EPSTD or Early and Periodic
Screening, Diagnosis, and Treatment Program (Medicare Coverage of Hearing Aids). In
recent years coverage, specifically for cochlear implants has expanded. Medicare and the
Veteran’s Administration offer at least partial coverage and federal law mandates that
Medicaid cover the procedure for any child under 21 who qualifies (Cochlear Implant
Frequently Asked Questions). The coverage for private insurance varies greatly
depending on each independent provider but many private health insurance companies
consider hearing aids and cochlear implants “exclusions,” which a term insurance
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companies use for the conditions and treatments that are not covered by a policy
(Hoffman 98).

The health care system in the U.S. suffers from perverse incentives, that send
contradictory messages to both the public and health care professionals. The
commoditization of American health insurance was perpetuated by the social conditions
created by World War II. During the war President Franklin Delano Roosevelt froze the
wages of workers. In order to recruit and retain workers, employers turned to enhancing
fringe benefits, such as healthcare coverage. Private insurers were already on the scene in
the forms of both Blue Cross and Blue Shield and were very successful. During such a
tumultuous time major reform in a system that was working perfectly fine seemed to be a
waste of resources. In the opinion of some, America missed her chance to implement
universal coverage during FDR’s presidency when Britain was accepting the Beveridge
Report and using FDR’s own terminology to make it a success. Britain came out with a
“cradle to grave” coverage system; America came out with an intricate system of
confusion (Blumenthal & Morone pp.21-56). Many small decisions in the health care
sector added up to produce today’s predicament where people who cannot afford
insurance are left without and even those who can are left without coverage for certain
medical procedures. As Beatrix Hoffman writes, since 1930 “The gap between public
expectations and the reality of the limited coverage led to discontent…” (90). Hearing
loss is a widespread example of this. The ability to hear is intrinsic to being human,
however, in the U.S. the hearing aid sector of the healthcare industry is treated mainly as
a commodity. Insurance companies are willing to pay for testing to determine if a person
suffers from hearing loss, however, they will not pay for hearing aids or surgery to fix the
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problem. Within in the framework of the world of those hard of hearing, a major problem
within the health sector is highlighted; is healthcare really a commodity or a right in the
United States?
According to the Robert Wood Johnson Foundation, “Four in five physicians say

patients’ social needs are as important to address as their medical conditions…” (Fenton).
Hearing loss is clearly classified as a medical condition but it seriously affects a patient’s
social needs as well augmenting the importance of preserving each individual’s ability to
hear. Multiple aforementioned studies have found negative social effects on both the
elderly and the young who are afflicted with such impairments. The ability to adequately
communicate and be communicated with is essential to the health, safety, and social well
being of patients. Why then is something that is so basic to being human commoditized in
the U.S. healthcare system? The answer is American values.
In order to understand the mixed incentives of the current U.S. system, where
some aspects of health are treated as rights while others are treated as commodities, one
must understand the values that resulted in this system. The United States prides itself on
democracy, liberty, freedom, and free markets. American skepticism of anything that can
be labeled as socialist or has too much government involvement runs very deep. America
was born on the principle that this country would forever be a place where freedom
resides, as recorded by our founding fathers in the Constitution. Universal health
coverage, which would treat healthcare as a right for all, has been given the label
“socialized medicine” and is therefore seen as a threat to these American ideals. President
Dwight D. Eisenhower solidified the American values of competition, free markets, and
limited government involvement when he signed into law the employer-based health
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insurance system that is still the basis of the healthcare system in the U.S. today.

Eisenhower acted out of necessity to soothe public upheaval during a tumultuous time for
both foreign and domestic affairs during his presidency (Blumenthal & Morone 99-130).
Fear of government control, however, does not mean that America completely lacks
compassion and human sentiment. This is where the confusion begins.
Since the U.S. system is based on private health insurance plans, one would
assume that a person must purchase insurance, or receive it through their employer, in
order to access medical care at all. In a market system this is usually the case, however, in
the healthcare system it is not. Healthcare is treated as a commodity for the majority of
Americans, but what about a person who just got into a nearly fatal car accident and has
no insurance? The emergency medical response team is not going to leave that man to die
in the street, insurance or not. America possesses the most advanced healthcare in the
world and as the current world superpower it would be beyond barbaric to let citizens die
in the street because they could not afford coverage. That person will be taken to the
hospital and stabilized, regardless of cost to the hospital and providers. Similarly, to this
situation, if the same uninsured person were to walk into the ER after an accident, he or
she would be treated then as well. Written into laws, such as the Emergency Medical
Treatment and Labor Act or EMTALA, America provides safeguards for the uninsured
(EMTALA). The statutory provisions of EMTALA “…impose specific obligations on
certain Medicare-participating hospitals and critical access hospitals…” and “These
obligations concern individuals who come to hospitals “dedicated emergency
departments” and request examination or treatment for a medical condition and apply to
all of these individuals regardless of whether they are beneficiaries of any program under
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the act”(Medicare Program; EMTALA: Applicability to Hospital Inpatients and Hospitals
With Specialized Capabilities).
In Thomas Murray’s article, American Values and Health Care Reform he
discusses the implications of these American values. He writes, “Stewardship requires us
to be mindful of the basic needs of others and of the power and responsibility we have to
use the resources in our control to meet those needs” (Murray). Hearing is one of the five

basic senses, yet Americans are not mindful of this basic need and the cost of financing it.
Murray believes that the work of reforming the healthcare system must be accompanied
by a dialogue about what values should form the foundation of the system. These values
must be understood and reinforce one another in order to be successful (Murray). The
lesson here is a confusing one; America does not have formal universal healthcare
coverage, but in reality an informal system, or safety net, does exist.
Now we need to exam this issue in three different settings to underscore the
importance of the ability to hear and the impact that the lack of coverage due to the
commoditization of this sector of the healthcare industry has on everyday people. Let’s
consider three cases that underscore how hearing treatments are a commodity in the U.S.
Paul
My father watches the television on mute. Most people take advantage of the
volume settings on television sets, but it does not matter all that much if the
person watching it cannot hear. His hearing loss was gradual, and deteriorated
little by little over time. Years of farm work with heavy machinery, hunting with
high-powered rifles, and battling sinus infections due to environmental allergies
took their toll. When my dad watches television volume is a moot point; he reads
lips or risk blowing the speakers completely. Hearing aids have been around for
decades and are easily accessible in this affluent country that we reside in, so
why didn’t my father purchase a set the moment his hearing started to fail? The
answer is simple: money. My father has six children and, as a byproduct, more
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financial responsibilities than most. Hearing aides, whether surgically implanted

(cochlear implants) or external amplifiers are not covered by health insurance in
the United States. Like many parents, my father put the needs of his children
before his own needs for many years until his hearing loss interfered in his dayto-day activities. My father now owns Beltone Promise hearing aids, which cost
him $8,000 out of pocket. As a farmer, his ability to hear is vital to his safety on
the job while he is working with heavy machinery and communicating with labor
teams. My father suffers from severe hearing loss in his left ear and his right ear
suffers from moderate hearing loss.

As Jen Christensen notes, “Hearing loss is an ‘invisible,’ and widely uninsured

problem.” If a person loses a limb, insurance usually covers the cost of a prosthetic

limb; individuals with ED can obtain Viagra or other drugs through their insurance
company. This generous approach to coverage for disabilities does not extend to

hearing; in fact, hearing loss is not categorized as a disability. If it were, however,

hearing loss would rank as the number one disability class in the country. Hearing

aids, therefore, are considered an elective purchase. Only 19 states out of 50 require
health plans to cover hearing aids; only 3 out of those 19 states extend coverage to
adults as well as children. Even when private insurance does pay the only aspect

private insurers typically cover is the hearing exams that assess the level of loss. A

recent study conducted by Virginia Ramachandran who is a senior staff audiologist
in the Division of Audiology of the Henry For Hospital in Detroit, MI, showed that
75% to 80% of adults with hearing loss do not invest in hearing aids. The study
showed that the only group that consistently obtained hearing aids were those
individuals whose insurance paid for them in full (Christensen).
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Coverage for prosthetic limbs is much more expansive. Just as prostheses,

hearing aids and cochlear implants help to return a body to its fully functioning state
as best as possible, so why then do these devices not receive equal coverage?

Medicare Part B covers prosthetics limbs (Orthotics & Artificial Limbs). All 50 states

have at least partial coverage for prosthetic limbs under Medicaid (Medicaid

Benefits: Prosthetic and Orthotic Devices). Private insurance coverage varies though
most private insurance companies cover prostheses. This coverage may be capped
or have a lifetime limit (Financial Assistance for Prosthetic Services, Durable
Medical Equipment, and Other Assistive Devices).

My father’s case illustrates the plight of most American adults with a hearing

impairment. At 62 years old he is not yet eligible for Medicare, however, the

situation would not change much even if he were because Medicare also does not

cover most hearing aids. In order to exam the coverage, or lack there of, for hearing

services an examination of the Medicare, Medicaid, and private insurance policies is
necessary. Medicare Part B will cover diagnostic hearing tests and balance exams if
ordered by a health care provider in order to determine if treatment is necessary.
Medicare Part B will not cover routine hearing exams, fitting for hearing aids, or
hearing aids. Even for the covered exams the patient is still responsible for their
Part B deductible and 20% of the “Medicare approved amount” for the doctor’s
services (Hearing and balance exams & hearing aids).

Cochlear implant coverage under Medicare is different. CMS issued a decision

that “The evidence is adequate to conclude that cochlear implantation is reasonable and
necessary for treatment of bilateral pre-or-postlinguistic, sensorineural, moderate-to-
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profound hearing loss in individuals who demonstrate limited benefit from amplification”
(Decision Memo for Cochlear Implantation). However, hearing loss is so specific to
each individual and the various models of cochlear implants, which the FDA has

approved, made deciding how much to reimburse difficult for CMS. With regards to

reimbursement CMS concluded “Although we do not find sufficient evidence to support
across the board coverage of cochlear implantation for all persons who have hearing loss
scores ≤ 60% correct, a sufficient inference of benefit can be drawn to support limited
coverage in the context of a clinical trial that provides rigorous safeguards for patients”
(Phurrough).
There is some hope for the private insurance sector to take on more coverage

since the ACA lists hearing aids as a standard health benefit. Hearing aids are listed
number 36 on HHS’s benchmark plan format for each state. Unfortunately, each

state is only required to meet the first ten essential benefits set out by the ACA. HHS

clearly seems to recognize that haring aid coverage should be considered a standard
component of health insurance plans (Hearing Aids and the Affordable Care Act).

The commoditization of hearing has led to a complex and competitive market

for hearing aids and other assistive devices. It is important to remember that most
people purchasing hearing aids are age 65 or older. Elderly consumers are more
susceptible to high-pressure sales tactics and more trusting than the average

consumer. A study conducted by Eun-Jin Kim and Loren Geistfeld shows that

elderly vulnerability is a three dimensional phenomenon encompassing their health
status, cognitive ability, and social network, which all tend to degenerate with age
(Geistfeld & Kim). Door-to-door hearing aid dispensers take full advantage of this
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susceptibility and augment it by making sales within people’s homes. The

manufacturing, sale, and distribution of hearing aids if regulated by three bodies of
law that overlap: federal laws, state laws, and state licensing boards. Federal

regulations state that hearing dispensers are not permitted to sell hearing aids to an
individual who has not produced a statement signed by a licensed physician stating
that the patient has been medically evaluated and is a candidate for hearing aids.

Individuals can sign a waiver of the medical examination as long as the dispenser
notifies the client that the evaluation is in their best interest medically (Adams).

Signing this medical waiver can be extremely dangerous as Dr. Dennis Colucci, a

forensic audiologist from a private practice in Laguna Hills, CA, explains, “Ill-fitted

hearing aids come in all sizes and circuits from people who manufacture devices or are
licensed to fit and sell them. Blurry hearing aids not only worsen patients' social isolation
and deprivation, but they also result in public confusion and distrust.”
Licensing boards differ from state to state but they all serve the same basic

purpose, which is to “set standards for minimum competency, licensure, and

practice; investigate complaints; and discipline practitioners” (Adams). These boards

lack funding to be proactive and, therefore, often act retroactively when a complaint has
been filed. State to state differences for licensing hearing aid dealers make the system
complicated but and individual who fits the minimal requirement is generally someone
with a high school diploma or GED who is 18 years of age or older (Adams).
False or misleading advertisement is a huge impediment to the effective use of
hearing aids within the U.S. Dispensers abuse the regulations under which consumers can
waive their medical evaluation and misrepresent the benefits received from using hearing
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aids. In April of 1993 the FDA warned six manufacturers about misrepresenting the
capabilities of hearing aids (i.e. such as claiming that hearing aids could eliminate

background noise). Beltone, the company my father purchased his hearing aids from, was
one of the six companies cited by the FDA. In 1976 these six companies were also issued
consent orders against them by the Federal Trade Commission, which instructed them to
cease making “unreasonable” claims about their products’ abilities. Waiving one’s
medical examination may lead to the purchase of an ineffective or inappropriate model
for their type of hearing impairment (Adams).
Quality of life is at stake for my father and millions of other Americans who
suffer from hearing loss. Like my father, many hearing loss sufferers, especially the
elderly, take shame in undergoing the process for and making the purchase of assistive
devices. In 2010 -2011 the Ida Institute held a series of seminars on the theme Living
Well With Hearing Loss with their distinguished faculty Leslie Jones, PhD, Patricia
McCarthy, PhD, Christopher Lind, PhD, and Jean-Pierre Gagné, PhD. During the
seminar, the faculty highlighted the importance of recognition and acceptance of hearing
impairment. Once acceptance is achieved then audiological rehabilitation goals can begin
to be reached (Living Well With Hearing Loss). My father has financial concerns about
his hearing aids but admitting that he needed them was just as hard as handing over
$8,000. My father could easily recognize he had a problem but accepting that problem
and allowing others to see a physical sign that he is hard of hearing took about two years
for him to cope with.
Janet
My Aunt Janet, suffers from hearing loss of a different nature. Janet is a breast
cancer survivor who had a double mastectomy about 15 years ago and then
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survived lung cancer about 8 years ago by undergoing chemotherapy as well as
the partial removal of her left lung. The months of rigorous chemotherapy not
only caused my aunt to lose her hair and copious amounts of weight, but it also
caused her to lose much of her hearing. The University of Arizona Cancer
Centers notes, “Hearing loss has become one of modern cancer therapy’s most

prevalent side effects. In fact, hearing loss is among the most underreported, yet
potentially devastating, side effects endured by many chemotherapy patients”
(Prevenas). Patients often do not think about the fact that they could lose their
hearing from cancer treatment, nor do most of them care during such a pivotal
time. Patients also rarely recognize that they are losing their hearing until it is too
late for treatment because the loss first impacts higher frequencies, which are far
above the range of normal speech recognition (Prevenas). Janet is an
elementary level special needs teacher; the ability to hear is essential to her
profession. Should hearing aids not be covered as part of her full cancer
treatment since they would be a direct result of it?

Cancer treatment is very costly investment and the amount that patients will pay
out-of-pocket depends on their insurance plan, if they have any at all. Both public and
private insurance cover at least a portion of treatment costs and the uninsured can usually
gain assistance from public and private programs, such as the TANF program
(Temporary Assistance for Needy Families). The potential financial burden that comes
with a cancer diagnosis seems insignificant in the face of death. Although, cancer
treatments have made huge strides and more people are surviving various types of cancer
than ever before, there is a lurking threat of losing one’s hearing due to life saving
treatment and reducing the quality of the life they are trying so desperately to save. The
likelihood of a patient rejecting chemotherapy or radiology based on the risk of hearing
loss is so minimal that this problem has essentially been swept under the rug.
How do chemotherapy and radiation contribute to hearing loss? As Dr. Paul
Gidley explained, toxicities from chemotherapy treatment cause nerve damage, which
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results in the loss of hearing, or ototoxicity. Gidley's subspecialty is otology and

neurotology, which means he specializes in the care of chronic ear disease (Q&A: Cancer
and Hearing Loss). This type of hearing loss is sensorineural and is most often
permanent. High doses of radiation near the ear or to the brain can cause inflammation
and subsequent wax build up in the outer ear, fluid build up in the inner ear, or stiffness
within the middle ear bones or eardrum. These problems can result in conductive hearing
loss, which may improve over time but may also be permanent (Hearing Loss,
Vanderbilt-Ingram Cancer Center). A study on sensorineural hearing loss after
chemotherapy and radiation was published in the Clinical Journal of Oncology and found
that patients who received radiotherapy and chemotherapy suffered from greater
sensorineural hearing loss than those who only received radiotherapy. High frequency
sounds in the speech range were especially impacted. (Kein Low).
Prior to treatment the University of Arizona Cancer Center strongly suggests that
patients undergo a baseline audiogram that focuses on high frequencies, Distortion
Product Otoacousitc Emissions (to test inner ear cell hair function), and
videonystagmography (to evaluate balance function). Patients should have follow up tests
done at pre-determined intervals by an audiologist and should also make contact with
neurotologist or inner specialist in case hearing is impacted throughout treatment
(Chemotherapy-Induced Hearing Loss). The two main detriments to cancer patients’
hearing during treatment is radiation to the head or ear and chemotherapy from the
“platinum” group like cisplatin or carboplatin. The physical effects of this hearing loss
are balance issues, which means a greater likelihood for dangerous falls. Hearing loss has
also been linked to the development of certain forms of dementia. Psychologically
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depression, isolation, and anxiety are all results. Economically, there is a higher rate of
unemployment, an overall lower standard of living, and difficulty advancing in one’s
career. Although little statistical data is currently available, a landmark study of 67
chemotherapy patients between the ages 8-23 years old found that 61% of them
developed hearing loss after treatment. Most of the hearing loss experienced was high-

frequency loss. These treatments that save lives depreciate that same life’s value (Klop).
External and internal breast prostheses and post-surgical bras for breast cancer
patients who undergo mastectomies are covered by both public and private insurance.
Prosthetic breasts are merely an aesthetic or cosmetic surgery, which aims to restores
how the woman’s appearance before her mastectomy. Is the purpose of hearing aids not
to achieve the same goal? To return a person who is missing some feature to as close to
whole and functioning properly as possibly? Once again, prosthetic coverage raises the
question about why hearing aids and services are not covered. All women with Medicare
are covered for these procedures. Part B covers external prosthetic, post-surgical bras,
and breast reconstruction surgery performed in an outpatient setting. Part A covers
surgically implanted breast prostheses after a mastectomy in an inpatient setting (Breast
Prostheses). Private insurance coverage varies, however; generally external breast
prostheses are covered subject to specifications. For instance, some private insurance
companies do not cover custom breast prostheses because there is a standard model
available, which meets the medically necessary criteria. Prosthetic replacements due to
changes in size are usually covered by insurance as long as a prescription with reasoning
for the replacement is provided by a doctor (Breast Prosthesis).
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As was the case with my aunt, many women feel that procuring prostheses after

mastectomies helps them cope with such a drastic change and permanent bodily change.
The prostheses essentially raise the quality of the patients’ life by keeping their selfesteem intact after such a hard fought battle. If purely cosmetic surgical and non-surgical
coverage is extended to cancer patients as part of their care then why shouldn’t hearing
aids and cochlear implants also be covered? There are ample studies that show the
improved quality of life that these devices provide to their users. To give a patient a new
lease on life only to have her faced with the great physical and financial burden of
hearing loss is counterproductive.
Jamison –age fourJamison suffers from moderate hearing loss and underwent two surgeries to
have tubes surgically implanted in his ears to improve his hearing. Tube
implantation requires small tubes to be placed in the eardrums to help ventilate
the area behind the eardrum. This equalizes pressure as well as drains fluid to
keep the middle ear pressure closer to atmospheric pressure (Middle Ear
Infections and Ear Tube Surgery). Jamison is a wonderful little boy, but his
frustration over not being able to hear well manifests itself in his behavior. Before
his second surgery to replace his original tubes, Jamison began having
uncharacteristic and frequent tantrums. His speaking voice became more childish
and his pronunciation less clear. Jamison may not have a profession that his
hearing impairment can negatively effect but his fundamental language and
socials skills are mostly definitely impacted by his loss and in jeopardy of being
underdeveloped if he does not receive the proper treatment and intervention.

As previously mentioned children have a much wider range of coverage for
hearing benefits than do adults. Medicaid coverage of hearing benefits is an extremely
complex system in terms of adult coverage because each state sets its own standards and
there is not requirement within the federal guidelines that mandates each state to cover
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hearing benefits. Services are mandated, however, for children from birth until age 21.

The federal government requires that Medicaid cover audiological assessments, hearing
aid evaluations, and medically necessary hearing aid services, which includes hearing
aids, hearing accessories, and services (Medicaid Regulations). Although these benefits
are available the system is not perfect. A study on Medicaid reimbursement of children’s
hearing services published in the Official Journal of the American Academy of Pediatrics
found that Medicaid reimbursements are falling short. The study looked at 15 states in
which Medicaid, Medicare, and private insurance have comparable coverage for hearing
services and found that Medicaid reimbursement rates have been steadily declining and
that many states do not even have billing codes for a significant number of hearing
services need by children. The expansion of newborn hearing screening has added a
significant number of children to the pool of those who need these services. This study
raises questions about how well states are meeting federal guidelines because many
children cannot access the services they need (McManus).
Medicaid is also required to cover all children for cochlear implants up to age 21.
Research studies found that cochlear implants can result in net saving of $53,000 per
child, in stark contrasts to the more than $1 million average expected lifetime cost that
each child with profound hearing loss prior to language development will likely incur.
With the operation costing in total about $40,000 these savings are significant (Cochlear
Implant Frequently Asked Questions).
Jamison’s family is too affluent to qualify for Medicaid, so his family relies on
private insurance coverage. Cochlear implants are in his future within the next two years.
Most private health insurance companies provide cochlear implant coverage because the
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implants have been recognized as a standard treatment for severe to profound hearing

loss due to nerve deafness. It is important to note, however, that repairs and updates for
cochlear implants are not always covered by insurance (Cochlear Implant Frequently
Asked Questions). More than 90% of all the commercial health insurance plans in the
country cover cochlear implants. Managed care plans may be more restrictive about their
coverage. Additional warranties and insurance on the actual devices themselves can be
obtained from manufacturers but not private insurance companies (Nussbaum) Over
40,000 adults and 30,000 children in the United States are cochlear implant recipients,
however, only 7% of the people in this country who qualify for the implants are hearing
with this technology today (Hearing Loss Stats).
Hearing aids are widely accepted so policy changes on adding coverage will most
likely face opposition solely from the insurance companies who will have to pay the bills.
The hearing world may not realize, however, the amount of controversy that cochlear
implants, specifically, create within the deaf community of this country. In the world of
those who can hear or gradually lose their hearing, some hearing is considered better than
non at all. In the deaf world, the sentiment is exactly the opposite; the deaf would rather
be completely deaf rather than hard of hearing. Deaf children with deaf people do not see
their circumstances as a tragedy like hearing parents often do. Deaf parents of deaf
children see their child’s impairment as a blessing of sorts, because it will allow their
child to grow up fully immersed in deaf culture. The deaf community warns against the
surgeries potential risks, which include “anesthesia complications, facial nerve damage,
skin flap necrosis, meningitis, and permanent dizziness” (Gaines). The deaf community
also points out the variability of success with the devices.
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The ethical debate this causes brought both medical and legal biomedical ethics
considerations to cochlear implant policies. The medical community has verified that

cochlear implants are the best therapeutic option for people with profound hearing loss.
By biomedical ethics standards, cochlear implants have also been found to be valid as
long as implantations are analyzed on a case-by-case basis. This stipulation means that
ENT (ears, nose, and throat) physicians bear the ethical responsibility to properly assess
each child as well as provide the child’s parent/guardian with all the material information
or information pertinent to the procedure and receive formal written consent
(Ortohinolaryngol).
Cochlear implants were first marketed in 1972 and more than 1,000 of the
primitive models of these devices were implanted between 1972 and the mid 1980’s.The
FDA formally approved this model of the implant in November of 1984 and several
hundred children received the devices. By the end of the late 1980’s, most concerns about
long-term success and the safety of the implants had been resolved. Since then, the
technology for these implants increases with every passing year. Cochlear implants today
have much higher performance levels. Acceptance of the implants as assistive devices
grew rapidly throughout the 90’s and continues to do so today. Implants are increasingly
recommended by medical professionals and chosen by patients as well. There are two
major corporations that produce cochlear implants in the United States, which are
Cochlear Corporation and Advanced Bionics Corporation (History of Cochlear Implants).
A study conducted on the effects of having cochlear implants in a world of
hearing people identified four principle conclusions about the devices’ long-term effects
for children. First, students with cochlear implants often experience great academic
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success but may still experience difficulties in a classroom setting. Second, the children
have strong and healthy relationships with hearing peers rather than hard of hearing
peers. Third, adolescents’ hearing-deaf identity was heterogeneous and ranged from
hearing to deaf. Finally, some adolescents with the implants may simultaneously have
more than one personal identity, which may be expressed at different intensities
according to their level of functioning and their circumstances (Adelman).
Time for Change
Congress is considering proposed legislation that would make hearing aids and
hearing healthcare part of the services and benefits covered by the federal Medicare
program. A Florida Republican, Mark Foley, introduced the bill last fall. Although
predictions that it will take years for Congress to pass any meaningful legislation on
hearing benefits may prove to be true, four state legislators have passed laws requiring
hearing benefits be covered for specific sectors of the population, mostly children, and
six other states are starting to follow suit. The private sector is also being pushed by
consumer demand to expand coverage. The hearing industry and manufacturers also

support an expansion in coverage for obvious reasons. Most campaigns, even before the
Foley Bill, are targeted at expanding coverage for children. James Potter, the director of
government relations and public policy at the American Speech-Language-Hearing
Association, points out that coverage for children is the logical sequel to the nationwide
campaign for newborn for newborn hearing screening, which made great progress and
won legislation mandating universal newborn hearing screening. As the baby boomers
now begin to reach the age for Medicare eligibility, there will be an even larger push
from that constituency.
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The Foley Bill, formally known as H.R. 2934, the Medicare Aural Rehabilitation
and Hearing Aid Coverage Act of 2001, would add hearing aids to the list of approved
durable medical devices covered by Medicare. Beneficiaries would then be entitled to
new hearing aids every three years if needed and patients would be billed personally if
they exceed their amount of coverage provided by Medicare. Potter sees this bill as well
intentioned but unlikely to pass, but will still be beneficial for raising awareness. The
Hearing Industries Association (HIA), which is the trade association for suppliers and
manufacturers of hearing products, support the Foley Bill but warn that reimbursement

would have to be high enough to keep manufacturers dedicated to innovation that benefit
the users of their products. HIA believes that the ability of patients to choose from a
variety of devices will need to be a significant part of any bill passed (Nemes).
Since 2002, bills that would create a federal income tax credit for individuals who
purchase hearing aids have been repeatedly introduced to Congress. This bill has never
come up for a vote but constantly gains more and more support over time. The original
version of the bill, known as the Hearing Aid Assistance Tax Credit or H.R. 1646,
provides a $500 tax credit per purchased hearing aid to by a hearing impaired person who
is 55 years of age or older or for a dependent child 18 years or younger. Other family
members who qualify as dependents for tax purposes are also covered by the act. The
newest version of the bill requires that a person must have an annual income under
$200,000 to receive the tax credit. The basic idea of this revision is to bring the total cost
of the act down by making those who can afford hearing aids pay for them. The bill has a
wide range of support from organizations such as the Hearing Loss Association of
America, HIA, ASHA, and the Academy of Doctors of Audiology. Tax credits are an
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expansion of third-party coverage. The only opposition the bill faces is that the federal

government would be losing revenue by allowing taxpayers to keep more of their money.
The Joint Committee on Taxation estimated in 2005 that the bill would cost the federal
government $300 million in one year and about $1.3 billion over five consecutive years
(Hearing Aid Assistance Tax Credit). Therefore, cuts would have to be made elsewhere
in the budget to make up for this benefit. The proposed tax credit would benefit many
individuals who already have insurance coverage for hearing services. For instance, Blue
Cross/Blue Shield FEHBP covers up to $1,200 per device despite the fact that on average
hearing aids cost $1,800 per device. A federal employee who buys a pair of hearing aids
for $3,500 could use the FEHBP coverage of $1,200 and also receive a $1,000 tax credit.
Some critics of the bill believe an insurance mandate on hearing benefits would be easier
because the government would not have to pay the bills (Victorian).
The implementation of the ACA holds some major implications for the future of
the hearing impaired percentage of the population. The enrollment of more individuals in
health insurance will more likely than not lead to more patients being referred to
audiologists for hearing-and-balance-related evaluations, which will increase the number
of people interested in hearing-benefit reform. Also, the actual number of hearing
impaired will statistically increase and reports will be more accurate. At present, 25 states
have already taken advantage of the option to expand Medicaid eligibility written into the
ACA and others may follow suit. The Medicaid eligibility expansion will result in
expanded hearing aid sales in those states and hearing benefits. As aforementioned, the
degree of covered care will vary in each state, however, the trend is to follow the
Massachusetts or “Romneycare” example, which expands hearing benefits. With the
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aging generation and expansion of hearing benefits audiologists are feeling pressure to
increase the quality of their services as well as their capacity for service. Competition

amongst audiologists through high-quality care at lower cost than other professionals in
the hearing health care field may promote direct access to hearing services (Parker).
Other reforms in the hearing services sector of health care would help simplify the
process and support coverage expansion with public and private insurers alike. One
element of reform should be increasing the transparency of hearing aid pricing. True
transparency would mean that practitioners would be expected to unbundle prices and
make the actual price of the hearing aid obvious separate from any other related charges
for professional services. Audiologists are often worried about sufficient reimbursement
for their services and transparency of cost will allow for the negotiation of reasonable
payment amounts. The development of better benchmarks and objective measurements of
the benefits of hearing treatment would also help coverage expansion grow. For example,
John Laftsidis, Alliances Manager of Beltone, believes that the hearing industry should
conduct a study to show employers how covering hearing benefits will benefit them in
the long run. Essentially, the main point of the study would be that employers should
cover hearing costs because employees who can hear better will perform better
(Victorian).
I believe a major reform that should be implemented is the removal of the option
to waive the medical evaluation before the purchase of hearing aids. Removing the option
to waive the medical evaluation would ensure that patients receive proper models and
fittings when they make their purchase. The requirement that patients see a physician
would also help data collection on this issue and more accurate statistics for the future.
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The fact that the hearing aid dispenser must inform the consumer that waiving their

medical evaluation is not in the best interest of his or her health is an indication to me that
it should not be an option in the first place. In a high stress financial and emotional
situation, people want to make the process as simple as possible, however, skipping the
step of seeing a physician prior to being fitted for and purchasing hearing aids is
counterproductive.
The best direction for this country to go in for expanding hearing benefit coverage
is to remove the option to waive the medical evaluation, pass the Foley Bill, and to make
hearing part of the new ACA benchmark essential benefits. A hearing aid assistance tax
credit like the one proposed above would put a large burden on the federal government
and leave private insurance companies unaccountable. Adding hearing benefits to the
essential benefits that plans must cover to participate in the insurance market place under
the ACA would acclimate private insurance to covering hearing benefits, which could be
easily expanded to all plans from there. Removing the option to waive the medical
evaluation will instantly increase the quality of services that each individual will receive
and cut down on wasted expenses, like improperly fitted hearing aids. Expanding hearing
coverage for adults to the level that children receive it is the next logical step for this
country. All newborns receive screening for possible hearing impairment, all children
have access to hearing coverage, now, adults need to be offered that same access.
As William M. Sage writes, “One person’s malady can harm families,
workplaces, clubs, churches, and sometimes entire communities” (Sage). The loss of
hearing is one of this country’s easily fixable maladies, which negatively impacts society,
yet we chose to ignore it. My father’s hearing affected my entire family and makes his
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job that much more dangerous. My aunt’s hearing makes teaching special needs

elementary school students even more of a challenge than it already is and Jamison’s
entire class of schoolmates is affected by his lack of hearing and subsequent behavior
issues. Sage goes on to say that “Effective reform must connect individual services to
population health at as many junctures as possible”(Sage). With increased hearing
services coverage the overall population of the country will be significantly healthier.
Mentally and physically, the impacts of hearing loss are all negative and the growing
number of individuals who will face hearing problems in the near future should be of the
upmost concern in the medical industry.
In a time of great change and reform for the health care sector of this country,
efforts to correct this grievous coverage gap should be in the forefront of reformers’
minds. Sage argues that “coordinated investment” is one of the aspects of American
solidarity in health care. He insists, ”Epidemics and disasters generate widespread
willingness both to contribute funds and to submit to physical restrictions in order to
prevent additional physical harm and to keep critical infrastructure functioning” (Sage). I
would argue that hearing impairments are a pandemic in this country of ghastly
proportions. The cause of much of the lack of accurate data and actual numbers for
hearing loss is commoditization of hearing services and devices. Turning patients into
solely consumers is a dangerous game to play when one of the person’s five senses is at
stake. Hearing device consumers are often under or uninformed, which leads to the
purchase of incorrect devices. The option to waive the medical evaluation is even more
precarious because it takes medical professionals out of the picture completely. Tax
credits for hearing aids purchasers and greater transparency in price are good first steps to
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integrating hearing coverage fully into the third-party payer system. However, I believe

that full coverage of hearing services and devices by both public and private insurance is
the direction this country should be headed in and is in fact, inevitable with the aging
baby boomer generation and the vastly increasing number of newborns who will now be
identified as hearing impaired through mandatory infancy screenings.
I know first hand how hearing loss impacts a relationship and an entire family.
My mother’s frustration at having to constantly raise her voice to have a normal
conversation, my father’s lack of participation in conversations at busy restaurants, and
rarely getting a response when I’d say “Love you Dad,” as he walked out the door to
work in the morning, all brought stress into our home. The difference that his hearing
aids make I his daily life is profound. Unfortunately for the hearing impaired treatment
comes with a very high price. My father was fortunate enough to be able to pay this price,
no matter how much anxiety the costly purchase caused him. The day after my father
purchased his hearing aids he walked out the door to work and when I called, “Love you
Dad,” he actually called back, “Love you too Reeg, but you don’t have to yell.”
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